Kate Grushetzkaya: The Essential Flow Cytometry Checklist – 6 Steps to Better Data
Kate Grushetzkaya, Flow Cytometry Specialist at Fred Hutch, shared a post on LinkedIn:
“Planning Flow Cytometry experiment? There is a checklist for you.
1. Titrate every antibody, don’t rely on the vial recommendation. Calculate Stain index and chose the best marker resolution for every color.
2. Block before you stain: use an Fc-receptor block rteagent to remove Fc-mediated nonspecific antibody binding.
3. When using more than one multiple Brilliant Violet (polymer) dyes in your panel, include an appropriate Brilliant Staining Buffer in the workflow.
4. Protect tandem dyes from sunlight: tandem-dye degradation can compromise compensation or unmixing.
5. Follow the three rules of compensation:
- Single-stained positive controls should be at least as bright as the corresponding signal in the experimental sample or brighter.
- Match background fluorescence between the positive and negative populations: bead controls should have negative beads, and cell controls should have matched negative cells.
- For single stained control, use the exact fluorochrome used in the experiment.
6.Design around autofluorescence, especially in myeloid samples: choose viability dyes and marker fluorochromes with signatures that can be distinguished from the autofluorescence profile.
7.Make the ‘Time gate’ your first quality-control gate: before interpreting biology, inspect the time parameter and gate on the stable interval.
8.Gate on single cells FSC-A vs. FSC-H plot: remove doublets from the analysis as they can cause false-positive signals or skewed populations.
9.Exclude dead cells: dead cells bind antibodies nonspecifically and can appear falsely positive across multiple parameters.
Did I miss something?”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 17:11Ken Kuang: Why Your Calves Are Called Your “Second Heart”?
-
Nov 9, 2026, 17:07Mert Dumantepe: Key Insights From The 8th Abu Dhabi International Vascular Conference
-
Nov 9, 2026, 16:57Amrita Sarkar: Exciting Advances in Hematology and Vascular Research at 54th Annual Philadelphia Workshop
-
Nov 9, 2026, 16:47Joey Boxer Samuels: Prolonged Sitting and Vein Thrombosis
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day